Logo image of QIA.DE

QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis

FRA:QIA - Deutsche Boerse Ag - NL0015002CX3 - Common Stock - Currency: EUR

40.21  -0.37 (-0.9%)

Fundamental Rating

6

Overall QIA gets a fundamental rating of 6 out of 10. We evaluated QIA against 17 industry peers in the Life Sciences Tools & Services industry. QIA has an excellent financial health rating, but there are some minor concerns on its profitability. QIA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

QIA had positive earnings in the past year.
In the past year QIA had a positive cash flow from operations.
In the past 5 years QIA has always been profitable.
In the past 5 years QIA always reported a positive cash flow from operatings.
QIA.DE Yearly Net Income VS EBIT VS OCF VS FCFQIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

The Return On Assets of QIA (1.47%) is worse than 64.71% of its industry peers.
With a Return On Equity value of 2.34%, QIA is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
The Return On Invested Capital of QIA (7.14%) is better than 70.59% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for QIA is in line with the industry average of 6.91%.
Industry RankSector Rank
ROA 1.47%
ROE 2.34%
ROIC 7.14%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QIA.DE Yearly ROA, ROE, ROICQIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of QIA (4.23%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of QIA has declined.
Looking at the Operating Margin, with a value of 25.02%, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
QIA's Operating Margin has improved in the last couple of years.
QIA's Gross Margin of 63.82% is amongst the best of the industry. QIA outperforms 94.12% of its industry peers.
QIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.02%
PM (TTM) 4.23%
GM 63.82%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QIA.DE Yearly Profit, Operating, Gross MarginsQIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QIA is destroying value.
Compared to 1 year ago, QIA has less shares outstanding
Compared to 5 years ago, QIA has less shares outstanding
Compared to 1 year ago, QIA has an improved debt to assets ratio.
QIA.DE Yearly Shares OutstandingQIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QIA.DE Yearly Total Debt VS Total AssetsQIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

QIA has an Altman-Z score of 4.40. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.40, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
QIA has a debt to FCF ratio of 2.77. This is a good value and a sign of high solvency as QIA would need 2.77 years to pay back of all of its debts.
QIA has a Debt to FCF ratio of 2.77. This is amongst the best in the industry. QIA outperforms 82.35% of its industry peers.
QIA has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.38, QIA is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 2.77
Altman-Z 4.4
ROIC/WACC0.96
WACC7.42%
QIA.DE Yearly LT Debt VS Equity VS FCFQIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

QIA has a Current Ratio of 3.61. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of QIA (3.61) is better than 100.00% of its industry peers.
A Quick Ratio of 3.09 indicates that QIA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.09, QIA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.61
Quick Ratio 3.09
QIA.DE Yearly Current Assets VS Current LiabilitesQIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.95%, which is quite good.
QIA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.25% yearly.
The Revenue has been growing slightly by 0.66% in the past year.
QIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.32% yearly.
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%

3.2 Future

Based on estimates for the next years, QIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.10% on average per year.
The Revenue is expected to grow by 7.82% on average over the next years.
EPS Next Y8.4%
EPS Next 2Y8.51%
EPS Next 3Y8.96%
EPS Next 5Y9.1%
Revenue Next Year4.26%
Revenue Next 2Y5.22%
Revenue Next 3Y5.83%
Revenue Next 5Y7.82%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QIA.DE Yearly Revenue VS EstimatesQIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QIA.DE Yearly EPS VS EstimatesQIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.21, the valuation of QIA can be described as rather expensive.
82.35% of the companies in the same industry are more expensive than QIA, based on the Price/Earnings ratio.
QIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.65.
With a Price/Forward Earnings ratio of 17.82, QIA is valued on the expensive side.
70.59% of the companies in the same industry are more expensive than QIA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.27. QIA is around the same levels.
Industry RankSector Rank
PE 20.21
Fwd PE 17.82
QIA.DE Price Earnings VS Forward Price EarningsQIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, QIA is valued a bit cheaper than the industry average as 64.71% of the companies are valued more expensively.
QIA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. QIA is cheaper than 64.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.96
EV/EBITDA 14.13
QIA.DE Per share dataQIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QIA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.4
PEG (5Y)2.45
EPS Next 2Y8.51%
EPS Next 3Y8.96%

0

5. Dividend

5.1 Amount

QIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

QIAGEN N.V.

FRA:QIA (6/23/2025, 7:00:00 PM)

40.21

-0.37 (-0.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners86.78%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.71B
Analysts76.67
Price Target43.91 (9.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-3.85%
Max EPS beat(2)3.38%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-3.85%
Max EPS beat(4)3.38%
EPS beat(8)5
Avg EPS beat(8)1.25%
EPS beat(12)9
Avg EPS beat(12)4.32%
EPS beat(16)13
Avg EPS beat(16)5.2%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.02%
Revenue beat(8)0
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.75%
PT rev (1m)-2%
PT rev (3m)-10.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.65%
EPS NY rev (1m)0.31%
EPS NY rev (3m)1.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE 20.21
Fwd PE 17.82
P/S 5.07
P/FCF 19.96
P/OCF 14.89
P/B 2.81
P/tB 11.96
EV/EBITDA 14.13
EPS(TTM)1.99
EY4.95%
EPS(NY)2.26
Fwd EY5.61%
FCF(TTM)2.01
FCFY5.01%
OCF(TTM)2.7
OCFY6.72%
SpS7.93
BVpS14.31
TBVpS3.36
PEG (NY)2.4
PEG (5Y)2.45
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 2.34%
ROCE 9.62%
ROIC 7.14%
ROICexc 9.2%
ROICexgc 29.06%
OM 25.02%
PM (TTM) 4.23%
GM 63.82%
FCFM 25.39%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score7
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 2.77
Debt/EBITDA 1.92
Cap/Depr 84.24%
Cap/Sales 8.66%
Interest Coverage 20.47
Cash Conversion 96.47%
Profit Quality 600.91%
Current Ratio 3.61
Quick Ratio 3.09
Altman-Z 4.4
F-Score7
WACC7.42%
ROIC/WACC0.96
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
EPS Next Y8.4%
EPS Next 2Y8.51%
EPS Next 3Y8.96%
EPS Next 5Y9.1%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
Revenue Next Year4.26%
Revenue Next 2Y5.22%
Revenue Next 3Y5.83%
Revenue Next 5Y7.82%
EBIT growth 1Y11.16%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year58.48%
EBIT Next 3Y22.89%
EBIT Next 5Y16.26%
FCF growth 1Y69.33%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y46.6%
OCF growth 3Y1.77%
OCF growth 5Y15.28%